1989 |
 |
Established as Dishman Ltd in Ahmedabad, India. 100% privately owned |
 |
Starting of quaternary ammonia (Quats) production on Naroda site |
|
|
1990 |
 |
First exports to Europe |
|
1995 |
 |
Leadership position in PTC-Quat business |
|
1996 |
 |
Forward integration into bulk intermediates and commencement of Bavla site |
|
1997 |
 |
Unit-I at Bavla commences production |
Dishman R&D
centre in Bavla (India) |
|
1998 |
 |
Establishment of marketing subsidiaries – Dishman Europe Ltd
and Dishman USA Inc |
 |
Units-II & III at Bavla commence production |
|
1999 |
 |
Unit-IV at Bavla commences production |
|
2000 |
 |
Unit-V at Bavla commences production |
|
2001 |
 |
Inauguration of units-VI B & VII: customer dedicated facilities |
|
2002 |
 |
Major EU pharma awarded first contract research project |
 |
Long-term toll manufacturing contract awarded by major EU pharma |
|
2003 |
 |
Conversion of entire Bavla facility into an Export Oriented Unit |
 |
Started supplies of clinical trial quantities of new compound under development |
 |
Acquired Chemconserve B.V in Netherlands, converted to Dishman Holland BV |
 |
Establishment of Dishman Africa Pty |
|
2004 |
 |
IPO: 25% of stock are issued on the Mumbai Stock Exchange to raise funds for further growth. The IPO was 40 times oversubscibed. |
 |
Dishman Europe receives the QUEENS
AWARD FOR ENTERPRISE "International Trade", on of
Britain's most prestigious awards for British
companies |
 |
Establishment of Dishman China |
|
2005 |
 |
IPO: 25% of stock are issued on the Mumbai Stock Exchange to raise funds for further growth. The IPO was 40 times oversubscibed. |
 |
Dishman Europe receives the QUEENS AWARD FOR
ENTERPRISE "International Trade", on of Britain's
most prestigious awards for British companies |
 |
Establishment of Dishman China |
|
2006 |
 |
Dishman acquired IO3S, ozonolysis specialist, of
Bern Switzelrand
www.io3s.com |
 |
Dishman completed the acquisition of Carbogen Amcis
in Switzerland |
 |
Dishman founded a Saudi Joint Venture, named CAD
Middle East Phamaceutical Industries, Ltd., to
manufacture APIs |
|
2007 |
 |
Establishment of Dishman Japan |
 |
Establishment of Dishman Australasia |
 |
Dishman acquired the fine chemicals, vitamin D and
vitamin D analogues business from Solvay
www.dishman-netherlands.com |
 |
Unit-I fully refurbished. Unit-VIII completed.
Unit-IX construction started. |
|